Establishment of Pancreatic β-Cell–Specific Gene Knockout System Based on CRISPR-Cas9 Technology With AAV8-Mediated gRNA Delivery
Diabetes · 2023
DOI: 10.2337/db23-0445 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, 2023. Verfasst von Kyosei Ueki und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Metabolism and Endocrinology, Juntendo University Graduate School of Medicine, Japan. Hauptthemen laut MEDLINE: Insulin-Secreting Cells, CRISPR-Cas Systems, Dependovirus, RNA, Guide, CRISPR-Cas Systems. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
The Cre-loxP system provides valuable resources to analyze the importance of tissue-specific gene knockout (KO), including pancreatic β-cells associated with the pathogenesis of diabetes. However, it is expensive and time consuming to generate transgenic mice harboring floxed genes of interest and cross them with cell-specific Cre expression mice. We establish a βCas9 system with mice expressing Cas9 in pancreatic β-cells and adeno-associated virus 8 (AAV8)–mediated guide RNA (gRNA) delivery based on CRISPR-Cas9 technology to overcome those shortcomings. Interbreeding CAG-loxP-STOP-loxP (LSL)-Cas9 with Ins1-Cre mice generates normal glucose-tolerant βCas9 mice expressing Cas9 with fluorescent reporter EGFP specifically in β-cells. We also show significant β-cell–specific gene KO efficiency with AAV8-mediated delivery of gRNA for EGFP reporter by intraperitoneal injection in the mice. As a proof of concept, we administered AAV8 to βCas9 mice for expressing gRNA for Pdx1, a culprit gene of maturity-onset diabetes of the young 4. As reported previously, we demonstrate that those mice show glucose intolerance with transdifferentiation of Pdx1 KO β-cells into glucagon-expressing cells. We successfully generated a convenient β-cell–specific gene KO system with βCas9 mice and AAV8-mediated gRNA delivery. Article Highlights
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Metabolism and Endocrinology, Juntendo University Graduate School of Medicine, Japan.
- Department of Endocrinology, Diabetes and Metabolism, Kitasato University School of Medicine, Sagamihara, Japan.
ORCID-Profile: Yuya Nishida
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Ueki, K., Nishida, Y., Aoyama, S., Uzawa, H., Kanai, A., Ito, M., Ikeda, K., Iida, H., Miyatsuka, T., & Watada, H. (2023). Establishment of Pancreatic β-Cell–Specific Gene Knockout System Based on CRISPR-Cas9 Technology With AAV8-Mediated gRNA Delivery. Diabetes. https://doi.org/10.2337/db23-0445
Vancouver
Ueki K, Nishida Y, Aoyama S, Uzawa H, Kanai A, Ito M, et al. Establishment of Pancreatic β-Cell–Specific Gene Knockout System Based on CRISPR-Cas9 Technology With AAV8-Mediated gRNA Delivery. Diabetes. 2023. doi:10.2337/db23-0445
BibTeX
@article{Ueki2023,
author = {Ueki, Kyosei and Nishida, Yuya and Aoyama, Shuhei and Uzawa, Hirotsugu and Kanai, Akiko and Ito, Minami and Ikeda, Koki and Iida, Hitoshi and Miyatsuka, Takeshi and Watada, Hirotaka},
title = {Establishment of Pancreatic β-Cell–Specific Gene Knockout System Based on CRISPR-Cas9 Technology With AAV8-Mediated gRNA Delivery},
journal = {Diabetes},
year = {2023},
doi = {10.2337/db23-0445}
}
EUVIMED